Zenith Epigenetics Corp.


Organization Profile

Zenith Epigenetics Corp. is a science driven organization with a unique drug discovery platform in the area of epigenetics. Focusing on the inhibition of BET bromodomains, Zenith has successfully identified novel compounds for diseases in the areas of oncology and autoimmune disease. Our strong organization allow us to efficiently and rapidly to explore and progress these molecules from discovery to pre-clinical development, and through partnerships building a pipeline of products for both niche opportunities as well as more common diseases.

Contact Information

Brad Cann
Chief Financial Officer
Tel: (403) 254-9252